Mumbai (Maharashtra) [India], June 5: India's first non-profit organization, The Indian Cancer Society (ICS), founded in 1951, celebrated 14 glorious years of the Childhood Cancer Survivorship Program through UGAM on 'Cancer Survivors Day' observed on 4th June 2023. Founded in 2009, with the
A new targeted therapy medicine can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening, according to an international trial co-led by UCLA. The discovery provides a potential new therapeutic option for those suffering from the slow-growi
"I am a last-stage cancer survivor. I run a campaign called 'Ride of Hope' where I have travelled solo across the country on my bike to meet cancer patients and common people to convey that there is a life after cancer. Apart from this, I run an NGO, 'Harteij Cancer Foundation," said Harteij
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
A study discovered that when ribociclib, a targeted therapy medicine, is added to hormone treatment, patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a substantial invasive disease-free survival advantage.
Bengaluru (Karnataka) [India], June 2: Dimple Parmar, Founder & CEO of ZenOnco.io, has been awarded the prestigious Cartier Women's Initiative Award 2023 for her significant contributions to the Indian cancer care ecosystem. Dimple Parmar started ZenOnco.io after losing her husband and I
SRK recently took time off his work and fulfilled a 60-year-old cancer patient Shivani's wish. The fan had expressed her wish of meeting him at least once in her life, and SRK surprised her through a video call.
Cisplatin is commonly used as a chemotherapeutic drug in the treatment of many solid tumours, including bladder, ovarian, and esophageal tumours. However, when it is metabolised by an enzyme called "cysteine conjugate beta-lyase 1 (CCBL1)," it is transformed to "thiol-cisplatin," a highly ac
Doctors are one step closer to establishing a risk biomarker that will warn them as to which of their paediatric stem cell transplant patients are likely to encounter sinusoidal obstruction syndrome (SOS), a potentially fatal side effect.
In the presence and patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, the first UAE Conference on Organ Transplantation for Cancer Patients, organised by the Emirates Oncology Society in cooperation with (Houston Methodist) for Global Health Services, k
Anthracyclines, a particular class of chemotherapy that breaks the DNA in cancer cells, have been reported to increase the risk of heart failure among young adult cancer survivors (between the ages of 18 and 39 at diagnosis) by 2.6 times.